The CLN.SW stock jumped 5.27% intraday to CHF 8.285 on 27 Feb 2026 after investors digested Clariant AG’s Feb 26 earnings release. Volume reached 221,628 shares versus an average of 848,481, signalling above-normal trading interest. Market reaction focused on reported EPS CHF 0.34 and management commentary that pushed the shares above the 50-day average of CHF 7.47.
CLN.SW stock intraday price action
Clariant AG (CLN.SW) on the SIX in Switzerland traded between CHF 8.20 and CHF 8.40 today, closing the intraday move at CHF 8.285 after opening at CHF 8.25. The one-day gain of 5.27% outpaced the Basic Materials sector’s 0.14% intraday change, indicating sector-relative strength.
CLN.SW stock: earnings link to the move
The immediate catalyst was the 26 Feb 2026 earnings release showing EPS CHF 0.34, which the market viewed as supportive of near-term profit recovery. Analysts highlighted improved operating margins and a positive surprise on net income growth, and that helped push the stock above its 50-day moving average CHF 7.4749.
CLN.SW stock valuation and financial metrics
Clariant trades at PE 24.44 with a market cap of CHF 2,728,053,427 and TTM EPS of CHF 0.34. Key ratios show P/S 0.67, P/B 1.43, and dividend per share CHF 0.42 implying a yield near 5.05%. Net debt to EBITDA sits around 3.05x, reflecting leverage that investors should watch.
CLN.SW stock technicals and trading signals
Technical indicators support the intraday strength: RSI 61.42 and price above both the 50-day (CHF 7.4749) and 200-day (CHF 7.8476) averages. Bollinger Bands show an upper band at CHF 8.83, suggesting room for momentum; on‑balance volume confirms buying pressure as volume hit 221,628 today.
CLN.SW stock Meyka AI grade and analyst context
Meyka AI rates CLN.SW with a score out of 100: 68.48 | Grade B | Suggestion HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, and analyst consensus. Independent analyst screens show a mixed picture: strong ROE and DCF signals but elevated debt ratios temper the recommendation.
CLN.SW stock risks, sector context and outlook
Risks include netDebt/EBITDA ~3.05x, cyclical demand in chemicals, and currency exposure in EUR and USD. The Basic Materials sector average PE is 18.58, placing Clariant’s valuation slightly above peers on earnings. Opportunities are margin recovery in Catalysis and cost discipline across divisions, which can support further upside if sustained.
Final Thoughts
CLN.SW stock moved sharply intraday after the Feb 26 earnings release, trading at CHF 8.285 with volume 221,628, and registering a 5.27% gain. Short-term technicals are constructive while valuation metrics show a mix of modest price multiples (PE 24.44) and attractive dividend yield (~5.05%). Meyka AI’s forecast model projects a quarterly target of CHF 9.00, an implied upside of +8.63% versus the current price CHF 8.285; forecasts are model-based projections and not guarantees. Our grade (B, HOLD) reflects improved earnings momentum offset by leverage. Active traders may follow momentum toward the Bollinger upper band CHF 8.83, while longer-term investors should weigh debt metrics and sector cyclicality. For live trade data visit our CLN.SW stock page at Meyka CLN.SW. For company details see Clariant’s investor site at Clariant Investors.
FAQs
Why did CLN.SW stock jump today?
CLN.SW stock rose after Clariant’s Feb 26 earnings showed EPS CHF 0.34 and improved profitability commentary; volume was above average at 221,628 shares, signalling stronger buying interest.
What is Meyka AI’s view on CLN.SW stock?
Meyka AI rates CLN.SW 68.48/100 (B, HOLD), balancing earnings momentum and dividend yield against leverage. This is informational and not financial advice.
What price target or forecast exists for CLN.SW stock?
Meyka AI’s forecast model projects a quarterly target of CHF 9.00, implying +8.63% upside versus CHF 8.285; forecasts are model-based projections and not guarantees.
What are the main risks for CLN.SW stock investors?
Key risks for CLN.SW stock include netDebt/EBITDA ~3.05x, cyclical demand in specialty chemicals, and currency exposure. Monitor margins and debt reduction progress.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)